Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft disease

Journal of Interventional Cardiology

Volumn 20, Issue 6, 2007, Pages 458-465

  Minutello, Robert M ^a,b   Bhagan, Sherrita ^a   Sharma, Atul ^a   Slotwiner, Alexander J ^a   Feldman, Dmitriy N ^a   Cuomo, Linda J ^a   Wong, S Chiu ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RESTENOSIS; REVASCULARIZATION; STENT; TREATMENT OUTCOME; VEIN GRAFT DISEASE;

AGED; AGED, 80 AND OVER; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SIROLIMUS; TREATMENT OUTCOME;

EID: 36549008097     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2007.00301.x     Document Type: Article

References (41)

1. Davis KB, Chaitman B, Ryan T, et al. Comparison of 15-year survival for men and women after initial medical or surgical treatment for coronary artery disease: A CASS (Coronary artery surgery study) registry study. J Am Coll Cardiol 1995 25 : 1000 1009.
2. Morwani JG, Topol EJ. Aortocoronary saphenous vein graft disease pathogenesis, predispositions, and prevention. Circulation 1998 97 : 916 931.
3. Fitzgibbon GM, Leach AJ, Kafka HP, et al. Coronary bypass graft fate: Long-term angiographic study. J Am Coll Cardiol 1991 17 : 1075 1080.
4. Fitzgibbon GM, Kafka HP, Leach AJ, et al. Coronary artery bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 1996 28 : 616 626.
5. Campeau L, Enjalbert M, Lesperance J, et al. The relation of risk factors to the development of atherosclerosis in saphenous vein bypass grafts and the progression of disease in the native circulation. N Engl J Med 1984 311 : 1329 1332.
6. Chen L, Theroux P, Lesperance J, et al. Angiographic features of vein grafts versus ungrafted coronary arteries in patients with unstable angina and previous bypass surgery. J Am Coll Cardiol 1996 28 : 1493 1499.
7. Weintraub WS, Jones EL, Craver JM, et al. Frequency of repeat coronary bypass or coronary angioplasty alter coronary artery bypass surgery using saphenous vein grafts. Am J Cardiol 1994 73 : 103 112.
8. Weintraub WS, Jones EL, Craver JM, et al. In-hospital and long-term outcome after reoperative coronary artery bypass graft surgery. Circulation 1995 92 : 1150 1157.
9. Weintraub WS, Jones EL, Morris DC, et al. Outcome of reoperative coronary bypass surgery versus coronary angioplasty after previous bypass surgery. Circulation 1997 95 : 868 877.
10. Schaff HV, Orzulak TA, Gersh BJ, et al. The morbidity and mortality of reoperation for coronary artery disease and analysis of late results with use of actuarial estimate of event-free survival. J Thorac Cardiovasc Surg 1983 85 : 508 515.
11. Pekyar S, Angiolillio DJ, Bass TA, et al. Saphenous vein graft disease. Miverva Cardioangiol 2004 52 : 379 390.
12. Platko WP, Hollman J, Whitlow PL, et al. Percutaneous transluminal angioplasty of saphenous vein graft stenosis: Long-term follow-up. J Am Coll Cardiol 1989 14 : 1645 1650.
13. Guzman LA, Villa AW, Whitlow P. New atherectomy devices in the treatment of old saphenous vein grafts: Are the initial results encouraging? Circulation 1992 86 : I780.
14. Altmann D, Popma JJ, Hong MK, et al. CPK-MB elevation after angioplasty of saphenous vein grafts. J Am Coll Cardiol 1993 21 : A232.
15. Hong MK, Popma JJ, Pichard AD, et al. The clinical significance of distal embolization after transluminal extraction atherectomy in diffusely diseased saphenous vein grafts. Am Heart J 1994 127 : 1296 1303.
16. De Feyter PJ, Van Suylen RJ, De Jaegere PPT, et al. Balloon angioplasty for the treatment of saphenous vein bypass grafts. J Am Coll Cardiol 1993 21 : 1539 1549.
17. Hankekamp CEE, Koolen JJ, Den Heyer P, et al. A randomized comparison between balloon angioplasty and elective stent implantation in venous bypass grafts: The Venestent study. Catheter Cardiovasc Interv 2003 60 : 452 457.
18. Wong SC, Popma JJ, Pichard AD, et al. Comparison of clinical and angiographic outcomes after saphenous vein graft angioplasty using coronary versus 'biliary' tubular slotted stents. Circulation 1995 91 : 339 350.
19. Wong SC, Baim DS, Schatz RA, et al. Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: The multicenter U.S. Palmaz-Schatz stent experience. J Am Coll Cardiol 1995 26 : 704 712.
20. Hong MK, Mehran R, Dangas G, et al. Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results. J Am Coll Cardiol 2001 38 : 150 154.
21. Savage MP, Douglas JS, Fischman DL, et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med 1997 337 : 40 47.
22. Keeley EC, Velez CA, O'Neill WW, et al. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol 2001 38 : 659 665.
23. Hong MK, Mehran R, Dangas G, et al. Comparison of time course of target lesion revascularization following successful saphenous vein graft angioplasty versus successful native coronary angioplasty. Am J Cardiol 2000 85 : 256 258.
24. Le May MR, Labinaz M, Marquis J, et al. Predictors of long-term outcome after stent implantation in a saphenous vein graft. Am J Cardiol 1999 83 : 681 686.
25. de Jaegere PP, van Domberg RT, de Feyter PJ, et al. Long-term clinical outcome after stent implantation in saphenous vein grafts. J Am Coll Cardiol 1996 28 : 89 96.
26. Ellis SG, Brener SJ, DeLuca S. Late myocardial ischemic events after saphenous vein graft intervention - importance of initially " nonsignificant" vein graft lesions. Am J Cardiol 1997 79 : 1460 1464.
27. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with a stenosis in a native coronary artery. N Engl J Med 2003 349 : 1315 1323.
28. Schofer J, Schulter M, Gerschlick AH, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: Double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003 362 : 1093 1099.
29. Schampaert E, Cohen EA, Schulter M, et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small coronary arteries (C-SIRIUS). J Am Coll Cardiol 2004 43 : 1110 1115.
30. Lemos PA, Saia F, Hofma SH, Daemen J, et al. Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction. J Am Coll Cardiol 2004 43 : 704 708.
31. Hoye A, Lemos PA, Arampatzis CA, et al. Effectiveness of the sirolimus-eluting stent in the treatment of saphenous vein graft disease. J Invasive Cardiol 2004 16 : 230 233.
32. Lee MS, Shah AP, Aragon J, et al. Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts. Catheter Cardiovasc Interv 2005 66 : 512 513.
33. Costa M, Angiolillo DJ, Teirstein P, et al. Sirolimus-eluting stents for treatment of complex bypass graft disease: Insights from the SECURE registry. J Invasive Cardiol 2005 17 : 399 400.
34. Chu WW, Rha SW, Kuchulakanti PK, et al. Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention. Am J Cardiol 2006 97 : 34 37.
35. Vermeersch P, Agostoni P, Verheye S, et al. Randomized double-blind comparison of sirolimus-eluting stent versus bare metal stent implantation in diseased saphenous vein grafts. J Am Coll Cardiol 2006 48 : 2423 2431.
36. Baim DS, Wahr D, George B, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aortocoronary bypass graft. Circulation 2002 105 : 1285 1290.
37. Stone GW, Rogers C, Hermiller J, et al. Randomized comparison of distal protection with a filter-based distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aortocoronary bypass grafts. Circulation 2003 108 : 548 553.
38. Moses JW, Leon MB, Popma JJ, et al SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003 349 : 1315 1323.
39. Savage MP, Douglas JS, Fischman DL, et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med 1997 337 : 740 747.
40. Mauri L, O'Malley AJ, Popma JJ, et al. Comparison of thrombosis and restenosis risk from the stent length of sirolimus-eluting stents versus bare metal stents. Am J Cardiol 2005 95 : 1140 1145.
41. Cohen DJ, Doucet M, Cutlip DE, et al. Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention. Circulation 2001 104 : 773 778.